HLA-DRA and cancer: To validate the dual epithelial-immune feature of MHC-II+ cancer cells, we performed multiple immunofluorescence staining in UC tissues and confirmed the coexpression of epithelial markers (pan-CK) and HLA-DRA in single cancer cells from MI tumours (Figure 6E).